Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73+0.01 (+0.58%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Processa Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Processa Pharmaceuticals's market cap was $5.22M on Nov 11, 2026, against $13.69M a year earlier. Over the last 5 years it ranged from $954.56K to $76.44M, with a median of $6.34M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.22M | -14.2% |
| 2025 | Dec 31, 2025 | $6.09M | +110.9% |
| 2024 | Dec 31, 2024 | $2.89M | -65.0% |
| 2023 | Dec 29, 2023 | $8.24M | -52.9% |
| 2022 | Dec 30, 2022 | $17.48M | -77.1% |
| 2021 | Dec 31, 2021 | $76.44M | +101.0% |
| 2020 | Dec 31, 2020 | $38.02M | -61.5% |
| 2019 | Dec 31, 2019 | $98.76M | -29.1% |
| 2018 | Dec 31, 2018 | $139.23M | -51.9% |
| 2017 | Dec 29, 2017 | $289.70M | +463.5% |
| 2016 | Dec 30, 2016 | $51.41M | -37.5% |
| 2015 | Dec 31, 2015 | $82.26M | -76.2% |
| 2014 | Dec 31, 2014 | $346.36M | – |
See a number that looks wrong?